InMode Ltd. (INMD)
| Market Cap | 782.89M -19.1% |
| Revenue (ttm) | 374.63M -6.7% |
| Net Income | 77.51M -56.6% |
| EPS | 1.22 -52.0% |
| Shares Out | 57.48M |
| PE Ratio | 11.19 |
| Forward PE | 10.29 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 142,471 |
| Open | 13.73 |
| Previous Close | 13.72 |
| Day's Range | 13.57 - 13.80 |
| 52-Week Range | 12.72 - 16.67 |
| Beta | 2.03 |
| Analysts | Hold |
| Price Target | 16.17 (+18.72%) |
| Earnings Date | Nov 11, 2026 |
About INMD
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally. It offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women’s health conditions and procedures. The ... [Read more]
Financial Performance
In 2025, InMode's revenue was $370.50 million, a decrease of -6.16% compared to the previous year's $394.82 million. Earnings were $93.83 million, a decrease of -48.24%.
Financial StatementsAnalyst Summary
According to 5 analysts, the average rating for INMD stock is "Hold." The 12-month stock price target is $16.17, which is an increase of 18.72% from the latest price.
News
Steel Partners issues open letter to InMode stakeholders
Steel Partners, a significant, long-standing shareholder of InMode (INMD), issued an open letter to all InMode stakeholders. “Steel Partners Holdings is a significant, long-standing shareholder of InM...
Steel Partners Holdings L.P. Issues Open Letter to All InMode Stakeholders and Sets October 30, 2026 Expiration for Its $16.75 Per Share All-Cash Offer
NEW YORK--(BUSINESS WIRE)--Steel Partners Holdings L.P. (together with its affiliates, “Steel”), a significant, long-standing shareholder of InMode Ltd. (“InMode” or the “Company”) (Nasdaq: INMD), tod...
InMode sees Q3 revenue $91.8M-$92M, consensus $91.59M
InMode (INMD) is currently finalizing its financial results for the third quarter of 2026. While complete financial information and operating data are not yet available, set forth above are certain…
InMode sees FY26 revenue $365M-$375M, consensus $370.27M
As the company’s Special Committee continues its evaluation of a strategic proposal, InMode (INMD) will not host an investor conference call or webcast in connection with its third quarter 2026…
InMode to Report Third Quarter 2026 Financial Results on November 11, 2026, Expects Third Quarter Revenue of $91.8 Million to $92.0 Million, Reiterates FY 2026 Revenue Guidance Between $365M-$375M
YOKNEAM, Israel, Oct. 13, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial result...
InMode Advances RF Microneedling Comfort with the Launch of Morpheus8 Cool
IRVINE, Calif., Sept. 9, 2026 /PRNewswire/ -- InMode Ltd.
InMode Earnings release: Q2 2026
InMode released its Q2 2026 earnings on August 5, 2026, summarizing the period's financial results.
InMode reports Q2 non-GAAP EPS 35c, consensus 33c
Reports Q2 revenue $95.6M, consensus $93.7M. “Overall revenue was consistent with the prior-year period, and we saw continued stability in our U.S. capital equipment business, reflecting steady custom...
InMode sees FY26 non-GAAP EPS $1.29-$1.34, consensus $1.32
Sees FY26 revenue $365M-$375M, consensus $370.26M. Sees FY26 Non-GAAP gross margin 74%-76%.
InMode Reports Second Quarter 2026 Financial Results: Quarterly GAAP Revenues of $95.6 Million, Consistent with the Second Quarter of 2025
YOKNEAM, Israel, Aug. 5, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced its consolidated financial results fo...
Steel Partners Urges InMode Shareholders to Vote AGAINST the Re-Election of Dr. Hadar Ron and AGAINST Extraordinary Special Committee Compensation at the July 30 Annual General Meeting
NEW YORK--(BUSINESS WIRE)--Steel Partners Holdings L.P. (together with its affiliates, “Steel”), a significant, long-standing shareholder of InMode Ltd. (“InMode” or the “Company”) (Nasdaq: INMD), tod...
Steel Partners requests rescheduling of InMode’s annual general meeting
Steel Partners Holdings L.P., a significant, long-standing shareholder of InMode (INMD), issued a letter to the board of directors of the company. “Shareholders are aware of a going-private offer from...
Steel Partners Holdings L.P. Issues Letter to InMode Ltd.
NEW YORK--(BUSINESS WIRE)--Steel Partners Holdings L.P. (together with its affiliates, “Steel”), a significant, long-standing shareholder of InMode Ltd. (“InMode” or the “Company”) (Nasdaq: INMD), tod...
InMode price target raised to $17 from $14 at Baird
Baird analyst Jeff Johnson raised the firm’s price target on InMode (INMD) to $17 from $14 and keeps a Neutral rating on the shares. he firm updated its model following…
InMode to Report Second Quarter 2026 Financial Results on August 5, 2026, Expects Q2 Revenue Between $95.2M-$95.4M, Reiterates FY 2026 Revenue Guidance Between $365M-$375M
YOKNEAM, Israel, July 13, 2026 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial result...
InMode confirms receipt of unsolicited proposal from Steel Partners
InMode (INMD) confirmed that its Board of Directors has received the unsolicited letter and acquisition proposal from Steel Partners Holdings dated July 9, 2026. The Special Committee comprised solely...
InMode Confirms Receipt of Unsolicited Proposal
YOKNEAM, Israel, July 10, 2026 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD) (the "Company") confirmed that its Board of Directors (the "Board") has received the unsolicited letter and acquisition propos...
Steel Partners offers to acquire InMode for $16.75 per share in cash
Steel Partners Holdings, a significant, long-standing shareholder of InMode (INMD) issued a letter to the Board of Directors of the Company, offering to acquire 100% of the shares of InMode…
Steel Partners Offers to Acquire InMode for $16.75 Per Share in Cash
NEW YORK--(BUSINESS WIRE)--Steel Partners Holdings L.P. (together with its affiliates, “Steel”), a significant, long-standing shareholder of InMode Ltd. (“InMode” or the “Company”) (NASDAQ: INMD), tod...
DOMA Perpetual says InMode buyout proposal ‘materially undervalues’ company
DOMA Perpetual Capital Management, a significant stockholder of InMode (INMD), sent a letter to the Board of Directors of InMode. The letter states: ” As of the date of this…
DOMA PERPETUAL CAPITAL MANAGEMENT STRONGLY OPPOSES INMODE BUYOUT AS PROPOSED; PLANS TO VOTE AGAINST DEAL
DOMA ASSERTS THAT THE $16.20 PER SHARE OFFER MATERIALLY UNDERVALUES INMODE AND ITS LONG-TERM POTENTIAL DOMA BELIEVES THE BID EXPLOITS THE DEPRESSED VALUATIONS CREATED BY YEARS OF CEO-LED UNDERPERFORMA...
InMode confirms receipt of unsolicited $16.20 per share takeover proposal
InMode (INMD) announced that, on June 17, its board of directors received an unsolicited proposal from M.N. Business Strategy, Ltd. to acquire through a merger all of the outstanding ordinary…
InMode Transcript: Jefferies Global Healthcare Conference 2026
Management expects a flat revenue year amid market stabilization, with margin pressure from product mix and geographic shifts. New product launches, a specialized sales approach, and ongoing clinical studies aim to drive future growth, while capital allocation remains flexible.
InMode names Moshik Itzkovich as CFO, succeeding Yair Malca
InMode (INMD) announced the appointment of Dr. Shlomo Nass as Chairman of the company’s Board of Directors and Moshik Itzkovich as CFO, effective immediately. Moshik has held senior finance roles…
InMode Appoints Dr. Shlomo Nass as Chairman of the Board and Moshik Itzkovich as Chief Financial Officer
YOKNEAM, Israel, May 20, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode" or the "Company"), a leading global provider of innovative medical technologies, today announced the appointment of D...